Effect of troglitazone on radiation sensitivity in cervix cancer cells
Zhengzhe An, Xianguang Liu, Hyejin Song, Chihwan Choi, Won-Dong Kim, Jae-Ran Yu, Woo-Yoon Park
Radiat Oncol J. 2012;30(2):78-87. Published online 2012 Jun 30 DOI: https://doi.org/10.3857/roj.2012.30.2.78
Citations to this article as recorded by 
Peroxisome proliferator‐activated receptors as therapeutic target for cancer
Yuqing Wang, Feifei Lei, Yiyun Lin, Yuru Han, Lei Yang, Huabing Tan
Journal of Cellular and Molecular Medicine.2024;[Epub] CrossRef
PPAR-γ Modulators as Current and Potential Cancer Treatments
Tiange Chi, Mina Wang, Xu Wang, Ke Yang, Feiyu Xie, Zehuan Liao, Peng Wei
Frontiers in Oncology.2021;[Epub] CrossRef
PPARγ Agonists in Combination Cancer Therapies
Piotr Mrowka, Eliza Glodkowska-Mrowka
Current Cancer Drug Targets.2020; 20(3): 197. CrossRef
Rosiglitazone enhances radiosensitivity by inhibiting repair of DNA damage in cervical cancer cells
Zhengzhe An, Jae-Ran Yu, Woo-Yoon Park
Radiation and Environmental Biophysics.2017; 56(1): 89. CrossRef
T0070907 inhibits repair of radiation-induced DNA damage by targeting RAD51
Zhengzhe An, Jae-Ran Yu, Woo-Yoon Park
Toxicology in Vitro.2016; 37: 1. CrossRef
Chemotherapy and Chemoprevention by Thiazolidinediones
Eleonore Fröhlich, Richard Wahl
BioMed Research International.2015; 2015: 1. CrossRef
A new dawn for the use of thiazolidinediones in cancer therapy
Hardik Joshi, Tanushree Pal, CS Ramaa
Expert Opinion on Investigational Drugs.2014; 23(4): 501. CrossRef
Troglitazone and tumor inhibition: an evolving concept in the management of systemic malignancies
Shailendra Kapoor
Radiation Oncology Journal.2012; 30(4): 226. CrossRef